Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples